Asia Business News | Saturday, July 05, 2008
RSS 2.0  
 Benitec is an Australian biotechnology company focused on licensing its extensive intellectual property portfolio and developing therapeutics to treat serious diseases using its proprietary ddRNAi technology. Its current therapeutic program is focused on Human Immunodeficiency Virus (HIV). For additional information, please visit www.benitec.com
Company Headquarters Level 1, 123 Camberwell Rd 
    Hawthorn East Vic 3123 
    Australia 
Company Telephone +61 (0) 3 9811 9974 
Company Fax +61 (0) 3 9813 1201 
Company Principal Sector Health & Pharm 
Company Principal Industry Biotechnology 
Company Listed 1997/02/17 
Company Homepage www.benitec.com
 
Stock Exchange Stock Code
  ASX:BLTBLT
ZOBEXBJ9
EUREXBJ9
XETRABJ9
 PINK:BNIKFBNIKF
News Reader RSS   BENITEC LIMITED
 Benitec Limited (ASX:BLT) Delays Capital Raising Pending Restructure Of Relationship With CSIRO (MAY 23, 2008)
 Benitec Limited (ASX:BLT) To Raise A$5.1M Through Proposed Underwritten Non-Renounceable Rights Issue (MAY 16, 2008)
 Benitec Limited (ASX:BLT) Secures Further Rights to HIV Therapeutic Collaboration with City of Hope in HIV Trial (APR 29, 2008)
 Benitec Limited (ASX:BLT) Wins In US Supreme Court (APR 22, 2008)
Drag Podcast Icon To iTunes - Podcast Download for BENITEC LIMITED
 Benitec Limited ASX: BLT - Pfizer Granted Non-Exclusive Worldwide License to use Benitec Technology - Sue MacLeman, CEO (JAN 5, 2007)